9 recalls found for American Health Packaging. Check if any of your products are affected.
Meclizine Hydrochloride Tablets distributed nationwide by Amerisource Health Services LLC are being recalled. The two affected NDCs are 60687-775-65 and 60687-775-11. The recall is due to failed tablet specifications. Stop using the product and contact a healthcare provider for guidance immediately.
KVK-Tech Inc. recalled 31,676 packages of Oxycodone Hydrochloride Tablets on January 14, 2026. Defective seals may cause tablets to fall out, posing a health risk. Customers should stop using the product immediately and seek guidance from healthcare providers.
American Health Packaging recalled 27,868 blister packs of Sucralfate Tablets on October 9, 2025. The company filed for Chapter 11 bankruptcy, impairing its ability to monitor product quality. Consumers should stop using the product immediately and seek guidance from healthcare providers.
American Health Packaging recalled 360 cartons of Carbamazepine Extended-Release Tablets on September 15, 2025. The tablets fail to meet dissolution specifications, posing a risk to patients. Consumers should stop using the product immediately and consult healthcare providers for guidance.
American Health Packaging recalled 873 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall stems from the presence of a micro-organism in packaging material. No micro-organisms were found on the tablets themselves.
American Health Packaging recalled 2,708 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall follows the detection of a micro-organism in product packaging, though no contamination was found on the tablets themselves.
American Health Packaging recalled 1,062 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall stems from the detection of a micro-organism in auxiliary packaging materials. No micro-organism was found on the tablets themselves, but consumers should stop using the product immediately.
American Health Packaging recalled 1,757 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall stems from the detection of a microorganism in packaging materials, though no contamination was found on the tablets themselves. Consumers should stop using the product immediately and contact healthcare providers for guidance.
American Health Packaging recalled 26,992 blister packs of Sucralfate Tablets on July 29, 2025. The recall follows CGMP deviations that affect product quality. Consumers should stop using the product immediately and seek guidance from healthcare providers.